LyeTxI-b, a Synthetic Peptide Derived From a Spider Venom, Is Highly Active in Triple-Negative Breast Cancer Cells and Acts Synergistically With Cisplatin

Breast cancer is the most common cancer that affects women globally and is among the leading cause of women’s death. Triple-negative breast cancer is more difficult to treat because hormone therapy is not available for this subset of cancer. The well-established therapy against triple-negative breas...

Descripción completa

Detalles Bibliográficos
Autores principales: de Avelar Júnior, Joaquim Teixeira, Lima-Batista, Edleusa, Castro Junior, Célio José, Pimenta, Adriano Monteiro de Castro, Dos Santos, Raquel Gouvêa, Souza-Fagundes, Elaine Maria, De Lima, Maria Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114809/
https://www.ncbi.nlm.nih.gov/pubmed/35601827
http://dx.doi.org/10.3389/fmolb.2022.876833

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114809/
https://www.ncbi.nlm.nih.gov/pubmed/35601827
http://dx.doi.org/10.3389/fmolb.2022.876833

Ejemplares similares